- Home
- CLW vs ABEO Comparison
CLW vs ABEO Comparison
Compare CLW & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLW
- ABEO
- Stock Information
- Founded
- CLW 2005
- ABEO 1974
- Country
- CLW United States
- ABEO United States
- Employees
- CLW N/A
- ABEO N/A
- Industry
- CLW Paper
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- CLW Basic Materials
- ABEO Health Care
- Exchange
- CLW Nasdaq
- ABEO Nasdaq
- Market Cap
- CLW 293.0M
- ABEO 281.0M
- IPO Year
- CLW N/A
- ABEO 1980
- Fundamental
- Price
- CLW $17.41
- ABEO $4.51
- Analyst Decision
- CLW Strong Buy
- ABEO Strong Buy
- Analyst Count
- CLW 2
- ABEO 5
- Target Price
- CLW $30.00
- ABEO $18.20
- AVG Volume (30 Days)
- CLW 211.8K
- ABEO 2.9M
- Earning Date
- CLW 10-28-2025
- ABEO 11-12-2025
- Dividend Yield
- CLW N/A
- ABEO N/A
- EPS Growth
- CLW 875.72
- ABEO N/A
- EPS
- CLW 8.63
- ABEO 1.29
- Revenue
- CLW $1,556,100,000.00
- ABEO $400,000.00
- Revenue This Year
- CLW $13.91
- ABEO N/A
- Revenue Next Year
- CLW N/A
- ABEO $324.71
- P/E Ratio
- CLW $2.00
- ABEO $3.48
- Revenue Growth
- CLW 23.00
- ABEO N/A
- 52 Week Low
- CLW $16.53
- ABEO $3.93
- 52 Week High
- CLW $33.57
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- CLW 38.35
- ABEO 43.88
- Support Level
- CLW $17.68
- ABEO $4.37
- Resistance Level
- CLW $18.84
- ABEO $4.63
- Average True Range (ATR)
- CLW 0.68
- ABEO 0.32
- MACD
- CLW -0.06
- ABEO 0.02
- Stochastic Oscillator
- CLW 33.96
- ABEO 30.31
About CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.